Document Detail


Antihypertensive and hormonal activity of MK 954 in spontaneously hypertensive rats.
MedLine Citation:
PMID:  1396995     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
MK 954 (DuP 753), a recently developed angiotensin II (Ang II) receptor antagonist, was administered orally for 2 weeks to spontaneously hypertensive (SHR) and Wistar-Kyoto rats (WKY). Whereas the basal levels of plasma Ang II were lower in SHR than in WKY, treatment with MK 954 markedly reduced blood pressure in SHR but not in WKY. Plasma renin activity, Ang I and Ang II were increased, while plasma aldosterone was decreased in both strains. These results no only indicate therapeutic efficacy of this agent in the chronic treatment of human hypertension, but also support the idea that the renin-angiotensin system plays an important role in the control of blood pressure in SHR.
Authors:
K Mizuno; S Niimura; M Tani; H Haga; T Gomibuchi; H Sanada; S Fukuchi
Related Documents :
19884565 - Mammalian target of rapamycin is a critical regulator of cardiac hypertrophy in spontan...
9843895 - Dynamic exercise shifts the operating point and reduces the gain of the arterial barore...
1801005 - Pharmacological blockade of blood pressure and heart rate increases following milk inge...
6488025 - Lesions of the paraventricular nucleus alter the development of spontaneous hypertensio...
17703135 - Fasudil attenuates myocardial fibrosis in association with inhibition of monocyte/macro...
7265985 - A method for evaluating postural hypotension in conscious rabbits as a model to predict...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  European journal of pharmacology     Volume:  215     ISSN:  0014-2999     ISO Abbreviation:  Eur. J. Pharmacol.     Publication Date:  1992 May 
Date Detail:
Created Date:  1992-11-13     Completed Date:  1992-11-13     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  1254354     Medline TA:  Eur J Pharmacol     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  305-8     Citation Subset:  IM    
Affiliation:
Third Department of Internal Medicine, Fukushima Medical College, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angiotensin I / blood
Angiotensin II / antagonists & inhibitors*,  blood
Angiotensin-Converting Enzyme Inhibitors / pharmacology
Animals
Antihypertensive Agents / pharmacology*
Biphenyl Compounds / pharmacology*
Hormones / blood*
Hypertension / physiopathology*
Imidazoles / pharmacology*
Losartan
Male
Rats
Rats, Inbred SHR
Rats, Inbred WKY
Renin / blood
Renin-Angiotensin System / drug effects
Tetrazoles / pharmacology*
Chemical
Reg. No./Substance:
0/Angiotensin-Converting Enzyme Inhibitors; 0/Antihypertensive Agents; 0/Biphenyl Compounds; 0/Hormones; 0/Imidazoles; 0/Tetrazoles; 11128-99-7/Angiotensin II; 114798-26-4/Losartan; 9041-90-1/Angiotensin I; EC 3.4.23.15/Renin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Chronic morphine treatment causes down-regulation of spinal adenosine A1 receptors in rats.
Next Document:  Release of immunoreactive [Met5]enkephalin and cholecystokinin from the spinal cord by beta-endorphi...